Physician profile
Joel Boyd
NPI 1619970571
$39,415.96
in general payments reported to CMS, 2019-2025
6 companies · $846 in 2025
The $846 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,407 · 2021: $8,822 · 2022: $10K · 2023: $2,370 · 2024: $525 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693 · Travel and Lodging: $1,341 · Royalty Or License: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.39 |
| Travel and Lodging | $1,340.73 |
| Royalty Or License | $706.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $36,655.51 | 2019-2025 | Arthrex, Ar-1269s |
| Gemini Medical LLC | $1,448.13 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $456.22 | 2019-2022 | |
| Foundation Medical, LLC | $397.23 | 2023-2025 | |
| Stryker Corporation | $351.07 | 2024-2025 | Mako, Alphavent, Inspace |
| Djo, LLC | $107.80 | 2024-2025 | Procare, Raw Material |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.